Navigation Links
New Estimates For The Causes Of Child Deaths Worldwide

The most accurate estimates of the causes of child deaths to date, published in the March 26, 2005 of THE LANCET, reveal that worldwide more than 70% of the 10.6 million child deaths that occur annually are attributable to six causes: pneumonia (19%), diarrhoea (18%), malaria (8%), neonatal sepsis or pneumonia (10%), preterm delivery (10%), and asphyxia at birth (8%).

Robert Black (Johns Hopkins Bloomberg School of Public Health, Baltimore, USA) and colleagues in an independent group on child health epidemiology, along with those from the World Health Organisation (WHO), analysed available data from publications and ongoing studies in 2000 to 2003 to obtain new estimates for mortality by cause in children younger than age 5 years. They found the four communicable disease categories account more than half (54%) of all child deaths. Infection of the blood or pneumonia in newborn babies and pneumonia in older children constitute 29% of all deaths. Undernutrition is an underlying cause of 53% of all deaths in children aged younger than 5 years. The investigators also calculated the total numbers and proportional distributions of deaths in children younger than age 5 years by cause for the six WHO-defined regions. Among deaths in children, 42% occur in the WHO Africa region, and an additional 29% occur in the south-east Asia region.

The authors state that the causes of child deaths can be addressed through existing, available, and affordable interventions. Reducing deaths in the neonatal period will confront health systems with new challenges, especially in low-income countries they add. (See The Lancet Neonatal Survival Series, March 2005)

Professor Black comments: "Achievement of the millennium development goals of reducing child mortality by two-thirds from the 1990 rate will depend on renewed efforts to prevent and control pneumonia, diarrhoea, and undernutrition in all WHO regions, and malaria in the Africa region. In all regions, deaths in th
'"/>

Source:Lancet


Page: 1 2

Related biology news :

1. South African Tribunal Asks For Damages Estimates in GSK AIDS Drug Case
2. Missing Receptor Molecule Causes Tumor Growth
3. Childrens taste sensitivity and food choices influenced by taste gene
4. Stem Cells Found In Cerebellum; Possible Cell of Origin for Childhood Brain Tumors
5. Children overprescribed antibiotics for sore throat
6. Children of allergy sufferers prone to same problem
7. Childhood obesity among Quebec Cree raises concerns
8. Children who sleep more weigh less
9. A frown or a smile? Children with autism cant discern
10. Measles Deaths Worldwide Drop By Nearly 40% Over Five Years
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Estimates For The Causes Child Deaths Worldwide

(Date:5/23/2013)... (May 23, 2013) A new report from ... for helping pupils engage in at least 60 minutes ... day. , No more than half of American youth ... of vigorous or moderate intensity physical activity daily, according ... "Because children are in school for nearly half of ...
(Date:5/23/2013)... Inside the natural history museums of the world are ... and beetles to flowers, mushrooms and grasses, all stacked, ... The rich and diverse collections could be critical to ... face of a growing human footprint if only ... project, brought to life with the help of a ...
(Date:5/23/2013)... reveal the interplay of brain chemicals which help us ... and BBSRC. , By changing the way neurons ... While these changes can affect the strength of a ... that response. , Lead author Alex Thiele, ... others, you can make yourself better heard by speaking ...
Breaking Biology News(10 mins):Schools should provide students with daily physical activity, IOM recommends 2CU-Boulder helps tap crowds to digitize museum records of bugs and plants 2CU-Boulder helps tap crowds to digitize museum records of bugs and plants 3CU-Boulder helps tap crowds to digitize museum records of bugs and plants 4
... consistent quality images, resulting in ... higher accuracy and better user experience, WALL, ... BKYI), a leader in finger-based biometric,identification and wireless public ... U.S. Patent and Trademark Office issued US patent,No. 7,359,553 ...
... A team of researchers led by scientists at Cold Spring ... that allow the pituitary glands of mice to grow even ... stem cells, these cells are distinct from those that fuel ... a novel way that the hormone-secreting gland may adapt, even ...
... University] Many of society,s most pressing problems ... drinking water, rooting out the biomarkers of diseases ... and nanoscale level. Such complex research is no longer ... disciplines, involving scientists with varied backgrounds and expertise. ...
Cached Biology News:BIO-key(R) Granted Image Identification System Patent for Award Winning Biometric Technology 2BIO-key(R) Granted Image Identification System Patent for Award Winning Biometric Technology 3Scientists find stem cells for the first time in the pituitary 2Scientists find stem cells for the first time in the pituitary 3Brown opens institute for molecular and nanoscale innovation 2
(Date:5/24/2013)... New York, NY (PRWEB) May 24, 2013 ... help the public protect themselves from the looming higher risk ... Cleaning Products published a new bed bug guideline. In the ... of bed bugs and avoiding them while traveling. ... why there is an increase of bed bug infestation during ...
(Date:5/24/2013)... 24, 2013 Senomyx , Inc. (NASDAQ: ... science technologies to discover, develop, and commercialize novel flavor ... , Ph.D., the Company,s Vice President, Biology and ... & Corporate Communications, will present an overview of Senomyx,s ... a.m. Eastern Time (7:25 a.m. Pacific Time) during the ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 Many factors ... and uptake or efflux transporters at the blood-tissue barrier. ... related to unbound fractions in the tissue rather than ... these disposition challenges is required to guide lead optimization, ... identify any species-dependent variables that may impact the likely ...
(Date:5/24/2013)... Vestiage, Inc. (stock symbol "VEST") a publicly ... and development, sales and marketing of premium branded ... that it is awarding exclusive Vestiage territories in ... Skin Illuminating Facial Care. Qualified applicants can request ... email to info(at)vestiageinc(dot)com and putting RELUMA in the ...
Breaking Biology Technology:Steps for Getting Rid of Bed Bugs without Using Chemicals and Avoiding Them While Traveling Enumerated by My Cleaning Products in Its Latest Post 2Steps for Getting Rid of Bed Bugs without Using Chemicals and Avoiding Them While Traveling Enumerated by My Cleaning Products in Its Latest Post 3SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CITI 2013 GLOBAL CONSUMER CONFERENCE 2DMPK for Targeted Tissue Delivery: Solutions for the Most Challenging Part of Outsourcing, New Life Science Webinar Hosted by Xtalks 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 3Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 4Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 5
... in the Trial,s First Stage ... Achieved Objective Tumor Responses- ... Calif., Oct. 21 Peregrine,Pharmaceuticals, Inc. (Nasdaq: PPHM ), a ... today announced that updated preliminary data from the first,stage of its ...
... sales progress being made as distribution channel ... BioElectronics Corp. (BIEL),the maker of ActiPatch(R) Therapy, ... battery operated microchip delivering continuous pulse,therapy that ... it has,achieved additional distribution penetration into the ...
... Healthcare Providers, LEXINGTON, Mass., Oct. 21 - ... award, and is now accepting,nominations. Award recipients will ... have demonstrated true passion for their,profession and have ... of,patient care. Three winners whose stories reflect uncommon ...
Cached Biology Technology:Peregrine Pharmaceuticals Reports Progress in Its Phase II Trial of Bavituximab Plus Docetaxel in Patients With Advanced Breast Cancer 2Peregrine Pharmaceuticals Reports Progress in Its Phase II Trial of Bavituximab Plus Docetaxel in Patients With Advanced Breast Cancer 3Peregrine Pharmaceuticals Reports Progress in Its Phase II Trial of Bavituximab Plus Docetaxel in Patients With Advanced Breast Cancer 4BioElectronics Announces Significant Progress in Canadian and International Distribution 2Instrumentation Laboratory Announces 'Passion & Results' Awards Program 2